Income tax expense · 2012–2025
Karyopharm Therapeutics income tax expense
$43,000−24.6% · FY2025
Karyopharm Therapeutics (KPTI) reported $43,000 in income tax expense for fiscal 2025, −24.6% year on year.
| Fiscal year | Income tax expense | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $43,000 | −24.6% | Open → |
| FY20242024-12-31 | $57,000 | −82.4% | Open → |
| FY20232023-12-31 | $323,000 | −12.5% | Open → |
| FY20222022-12-31 | $369,000 | +37.7% | Open → |
| FY20212021-12-31 | $268,000 | −13.3% | Open → |
| FY20202020-12-31 | $309,000 | +672.5% | Open → |
| FY20192019-12-31 | $40,000 | +53.8% | Open → |
| FY20182018-12-31 | $26,000 | −58.7% | Open → |
| FY20172017-12-31 | $63,000 | −54.7% | Open → |
| FY20162016-12-31 | $139,000 | +$118M | Open → |
| FY20152015-12-31 | −$118M | −$42.3M | Open → |
| FY20142014-12-31 | −$75.8M | −$41.8M | Open → |
| FY20132013-12-31 | −$33.9M | −$18.1M | Open → |
| FY20122012-12-31 | −$15.9M | — | Open → |
Income tax expense — Income tax expense is the tax a company charged against profit in its income statement for the year. It is not the same as the cash it handed to tax authorities: deferred tax, provisions and timing differences separate the two, often by billions. The cash figure is a different line in the cash-flow statement.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Income tax expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Karyopharm Therapeutics income tax expense |url=https://companiesranked.com/en/company/karyopharm-therapeutics/income-tax-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Karyopharm Therapeutics income tax expense. CompaniesRanked. https://companiesranked.com/en/company/karyopharm-therapeutics/income-tax-expenseBibTeX
@misc{companiesranked-en-company-karyopharm-therapeutics-income-tax-expense-2026,
author = {{CompaniesRanked}},
title = {{Karyopharm Therapeutics income tax expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/karyopharm-therapeutics/income-tax-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001193125-26-049397 · February 13, 2026
{{cite web |title=Karyopharm Therapeutics income tax expense — 10-K (0001193125-26-049397) |url=https://www.sec.gov/Archives/edgar/data/1503802/000119312526049397/kpti-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-13}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.